Global Virus Network
Global Virus Network (GVN) is a non-profit coalition coordinating 90+ virology Centers of Excellence across 40+ countries, dedicated to pandemic preparedness, viral surveillance, outbreak response, and training the next generation of virologists through research, education, and institutional partnerships.
- Company typePrivate
- Founded2011
- HeadquartersBaltimore, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Global Virus Network firmographics
Firmographics- Name
- Global Virus Network
- Legal name
- Global Virus Network
- Website
- https://gvn.org
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Global Virus Network (GVN) is a non-profit coalition coordinating 90+ virology Centers of Excellence across 40+ countries, dedicated to pandemic preparedness, viral surveillance, outbreak response, and training the next generation of virologists through research, education, and institutional partnerships.
- Ownership category
- akta.pro rank
Global Virus Network industry classification
Industry- Product category
- Virology Research Collaboration & Pandemic Preparedness
- NAICS
- Civic and Social Organizations (813410), International Affairs (92812)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Global Health Security & Pandemic Preparedness Partnerships (HLAJAOAH)
- akta.pro secondary industries
- Emerging Pathogen & Outbreak Response Testing Networks (HLAJAIAE), Immunization & Vaccine Access Partnerships (Global Vaccine Alliances) (HLAJAOAF)
Keywords
Where Global Virus Network is headquartered
LocationHeadquarters
- HQ city
- Baltimore
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Global Virus Network business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Grant Funding and Philanthropic Support: As a non-profit 501(c)(3) organization, GVN operates through grant funding and philanthropic support. The organization awards pandemic preparedness research grants to scientists across multiple continents (e.g., $160,000 awarded in November 2025 to researchers across four continents). Revenue is derived from institutional partnerships, grants, and donations rather than commercial product sales.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Global Virus Network product offering
Product offeringCore offering
Global Virus Network (GVN) is a worldwide coalition of 90+ virology Centers of Excellence and Affiliates across 40+ countries that coordinates collaborative research, training, and pandemic preparedness initiatives. The organization delivers educational programs (webinars, short courses, mentorship), administers research grants, organizes international scientific meetings, and supports outbreak surveillance and response. GVN operates as a non-profit 501(c)(3) rather than a product vendor.
Product overview
The Global Virus Network (GVN) is a worldwide coalition comprising 90+ Virology Centers of Excellence and Affiliates across 40+ countries. Rather than a single product, GVN offers a portfolio of programs and services focused on pandemic preparedness: educational offerings including the Forefront of Virology Webinar Series and Global Guardians High School Summer Program; research programs such as multi-country mpox diagnostic evaluations and pandemic preparedness grants; training initiatives including the Short Course in Translational Virology and Rising Star Mentorship Program; and annual scientific meetings. These offerings work together to advance viral research, foster next-generation virology leaders, and enhance global resources for readiness and response to emerging viral threats.
Differentiator
Problem solved
Functional benefit
Products and services
- Forefront of Virology Webinar Series
Quantifiable outcome
- Over 4.4 million deaths prevented globally each year through vaccination, which GVN supports through its pandemic preparedness mission
- +1 more outcomes
Companies that use Global Virus Network
Customer profileSegments3 records
Ideal customer profiles3 records
Global Virus Network technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Global Virus Network partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and flagship.
- Coalition for Epidemic Preparedness Innovations (CEPI)coreCEPI supports the Phase 3 clinical trial of Moderna's mRNA-based H5N1 vaccine candidate (mRNA-1018). GVN has highlighted this as an important step in global preparedness, building on its prior Lancet analysis recommending accelerated vaccine development alongside strengthened surveillance.
- Tampa General Hospital (TGH) Cancer InstitutecoreGVN co-hosted the 'Microbes, Genes & Cancer' Symposium with TGH Cancer Institute and USF Health Morsani College of Medicine in Tampa on March 2-3, 2026. This event marked the 50th anniversary of IL-2 discovery and covered HPV-related cancers, hepatitis-associated liver cancer, HIV-related comorbidities, and tumor-microbiome interactions.
- University of St AndrewscoreGVN's multi-country mpox diagnostic evaluation includes Dr. Wilber Sabiiti from University of St Andrews spearheading validation efforts in DRC and Uganda. Study compares rapid antigen tests against gold-standard PCR assays in resource-limited settings.
- Duke University School of MedicinecoreDuke University School of Medicine joined GVN as a Center of Excellence in February 2025, bringing the Duke Human Vaccine Institute's cutting-edge vaccine research capabilities against HIV-1, influenza, SARS-CoV-2, tuberculosis, syphilis, and gonorrhea.
- National Institute of Virology and Bacteriology (NIVB) - Czech RepubliccoreNIVB joined GVN as a Center of Excellence in February 2025, bringing together top Czech research institutes funded by EU's NextGenerationEU program to accelerate development of drugs and vaccines against viral and bacterial pandemic threats.
- Yale UniversitycoreYale University became a GVN Center of Excellence in February 2025, co-led by virologists in epidemiology, immunobiology, pediatrics, and laboratory medicine committed to collaborative research on viral disease prevention and control.
- University of Pennsylvania Perelman School of MedicinecorePenn's Perelman School of Medicine joined GVN as a Center of Excellence in February 2025, bringing expertise in coronavirus research, MERS-CoV spillover studies, and home to the Penn Center for Research on Coronaviruses and Other Emerging Pathogens.
- University of South Florida (USF)flagshipUSF hosts GVN's International Headquarters at the USF Health Institute for Translational Virology and Innovation (ITVI). This is GVN's most significant partnership, announced in June 2024 and officially opened March 5, 2026. Dr. Robert Gallo serves as James P. Cullison Professor of Medicine at USF and director of the ITVI. Dr. Sten Vermund serves as dean of USF Health College of Public Health and GVN's chief medical officer.
- Abbott LaboratoriescoreGVN and Abbott launched the Pandemic Defense Postdoctoral Fellowship Program in April 2022, training the next generation of virologists to combat future pandemic threats with focus on pathogen discovery in developing nations. Abbott serves as Corporate Partner. Gavin Cloherty, PhD leads Abbott's involvement.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Global Virus Network competitors and assessment
Company assessmentBroad incumbents
- World Health Organization (WHO): WHO is the UN's global public health authority coordinating international outbreak response, surveillance, and pandemic preparedness. It is a broader incumbent operating across all health domains; GVN frequently partners with and is positioned alongside WHO in outbreak briefings, making it the most prominent institutional peer for GVN's mission.
- Africa Centres for Disease Control and Prevention (Africa CDC): Africa CDC is the continental public health agency coordinating surveillance, preparedness, and outbreak response across African Union member states. As a larger, government-backed incumbent with overlapping outbreak-response and capacity-building mandates, it is a key institutional peer and partner for GVN's African Centers of Excellence.
Direct peers
- Institut Pasteur International Network: The Institut Pasteur International Network is a global federation of 32+ research institutes across five continents dedicated to infectious disease research and outbreak response. It directly overlaps GVN's virology Centers-of-Excellence model and shares senior leadership lineage (GVN board vice chair Bréchot is a former Institut Pasteur president).
- Foundation for Innovative New Diagnostics (FIND): FIND is a global non-profit accelerating the development and deployment of diagnostic tests, including for outbreak-prone infectious diseases. Its diagnostic-evaluation and access mandate aligns closely with GVN's multi-country mpox diagnostic evaluation and broader surveillance/early-detection agenda.
- Coalition for Epidemic Preparedness Innovations (CEPI): CEPI is a global coalition that finances and coordinates vaccine development against epidemic threats, with a mission and stakeholder base (governments, multilaterals, industry, scientists) directly comparable to GVN's pandemic preparedness mandate. Both operate as multi-stakeholder coalitions advancing preparedness research across viral families and collaborate on initiatives like Moderna's H5N1 mRNA-1018 trial.
- Gavi, the Vaccine Alliance: Gavi is a public-private global health alliance that accelerates vaccine access and immunization in lower-income countries. Like GVN, it is coalition-based, mission-driven around viral threats, and partners with WHO, governments, and industry; its scale and immunization focus make it a natural peer for GVN's pandemic preparedness and vaccine advocacy work.
Others
- Bill & Melinda Gates Foundation: The Gates Foundation is a leading philanthropic funder of global health, immunization, and pandemic preparedness initiatives. While not a coalition peer, it is a primary source of comparable funding and a frequent partner of GVN-adjacent organizations like Gavi and CEPI.
- International Science Council: The International Science Council is a global non-governmental organization that convenes scientific bodies and mobilizes the scientific community on issues including health emergencies. It is an adjacent, ecosystem-level peer to GVN's role as a scientific convening body for virology.
- Wellcome Trust: Wellcome is a major global charitable foundation funding biomedical research and pandemic preparedness, including infectious disease surveillance and capacity building. As a likely donor and aligned funder, Wellcome is a key ecosystem participant comparable to GVN's philanthropic support base.
Emerging players
- International AIDS Society (IAS): IAS is a professional society convening HIV/AIDS researchers, clinicians, and policymakers through global conferences and capacity-building programs. GVN has deep HIV-research roots through its founders (Gallo co-discovered HIV) and HIV-focused Centers of Excellence, making IAS a closely adjacent peer in convening and scientific community-building.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Global Virus Network social profiles
Digital presenceGlobal Virus Network financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Virus Network leadership team
Management profileNumber of profiles
Profiles4 records
Global Virus Network funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Virus Network M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Virus Network
What does Global Virus Network do?
Global Virus Network (GVN) is a worldwide coalition of 90+ virology Centers of Excellence and Affiliates across 40+ countries that coordinates collaborative research, training, and pandemic preparedness initiatives. The organization delivers educational programs (webinars, short courses, mentorship), administers research grants, organizes international scientific meetings, and supports outbreak surveillance and response. GVN operates as a non-profit 501(c)(3) rather than a product vendor.
Is Global Virus Network a public or private company?
Global Virus Network is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Global Virus Network founded?
Global Virus Network was founded in 2011. It employs 1 to 10 people.
Where is Global Virus Network based?
Global Virus Network is headquartered in Baltimore, United States, in the North America region.
How does Global Virus Network make money?
One revenue line is on record: grant Funding and Philanthropic Support.
Who are Global Virus Network's main competitors?
Broad incumbents on record are World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC). Direct peers are Institut Pasteur International Network, Foundation for Innovative New Diagnostics (FIND), Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance. Others are Bill & Melinda Gates Foundation, International Science Council and Wellcome Trust. International AIDS Society (IAS) is listed as an emerging player.
Does Global Virus Network have an API?
No public API is recorded for Global Virus Network.
What industry is Global Virus Network in?
Global Virus Network's product category is Virology Research Collaboration & Pandemic Preparedness. Its primary akta.pro industry code is HLAJAOAH, Global Health Security & Pandemic Preparedness Partnerships, with a secondary code of HLAJAIAE, Emerging Pathogen & Outbreak Response Testing Networks. Its NAICS code is 813410 and its SIC code is 8600.